Ser234Leu missense mutation in the A1 domain of factor V causing moderate factor V deficiency in a Chinese family

References

• Dahlback B. Blood coagulation. Lancet 2000; 355: 1627–1632
   PubMed Web of Science ®Google Scholar
• Mann K G, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20–30
   PubMed Web of Science ®Google Scholar
• Foster W B, Nesheim M E, Mann K G. The factor Xa-catalyzed activation of factor V. J Biol Chem 1983; 258: 13970–13977
   PubMed Web of Science ®Google Scholar
• Suzuki K, Dahlback B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556–6564
   PubMed Web of Science ®Google Scholar
• Kalafatis M, Rand M D, Mann K G. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869–31880
   PubMed Web of Science ®Google Scholar
• Owren P A. New factors concerned in the coagulation of blood. Bull Schweiz Akad Med Wiss 1947; 3: 163–177
   PubMedGoogle Scholar
• Castaman G, Lunghi B, Missiaglia E, et al. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V. Br J Haematol 1997; 99: 257–261
   PubMed Web of Science ®Google Scholar
• Guasch J F, Lensen R P, Bertina R M. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is ‘pseudo homozygous’ for activated protein C resistance. Thromb Haemost 1997; 77: 252–257
   PubMed Web of Science ®Google Scholar
• Lunghi, Castoldi E, Mingozzi F, et al. A novel factor V null mutation detected in a thrombophilia patient with pseudo homozygous APC-resistance and in an asymptomatic unrelated subject. Blood 1998; 92: 1463–1464
   PubMed Web of Science ®Google Scholar
• Castoldi E, Kalafatis M, Lunghi B, et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost 1998; 80: 403–406
   PubMed Web of Science ®Google Scholar
• Zehnder J L, Hiraki D D, Jones C D, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost 1999; 82: 1097–1099
   PubMed Web of Science ®Google Scholar
• Steen M, Miteva M, Villoutreix B O, et al. Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized. Blood 2003; 102: 1316–1322
   PubMed Web of Science ®Google Scholar
• Enjolras N, Plantier J L, Rodriguez M H, et al. Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion. J Thromb Haemost 2004; 2: 1143–1154
   PubMed Web of Science ®Google Scholar
• Asselta R, Tenchini M L, Duga S. Inherited defects of coagulation factory V : the hemorrhagic side. J Thromb Haemost 2006; 4: 26–34
   PubMed Web of Science ®Google Scholar
• Zhou R F, Fu Q H, Wang W B, et al. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis. Thromb Haemost 2005; 94: 1172–1176
   PubMed Web of Science ®Google Scholar
• Chen T Y, Lin T M, Chen H Y, et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency: molecular characterization by expression of the recombinant protein. Thromb Haemost 2005; 93: 614–615
   PubMed Web of Science ®Google Scholar
• Duga S, Montefusco M C, Asselta R, et al. Arg2074Cys missense mutation in the C2-domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood 2003; 101: 173–177
   PubMed Web of Science ®Google Scholar
• Montefusco M C, Duga S, Asselta R, et al. Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. Blood 2003; 102: 3210–3216
   PubMed Web of Science ®Google Scholar
• Yamakage N, Ikejiri M, Okumura K, et al. A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene. Haemophilia 2006; 12: 172–178
   PubMed Web of Science ®Google Scholar
• Steen M, Villoutreix B O, Norstrom E A, et al. Defining the factor Xa-binding site on factor Va by site-directed glycosylation. J Biol Chem 2002; 277: 50022–50029
   PubMed Web of Science ®Google Scholar
• Heeb M J, Kojima Y, Hackeng T M, et al. Binding sites for blood coagulation factor Xa and protein S involving residues 493–506 in factor Va. Prot Sci 1996; 5: 1883–1889
   PubMed Web of Science ®Google Scholar
• Kojima Y, Heeb M J, Gale A J, et al. Binding site for blood coagulation factor Xa involving residues 311–325 in factor Va. J Biol Chem 1998; 273: 14900–14905
   PubMed Web of Science ®Google Scholar
• Kalafatis M, Beck D O. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323–331 of factor V represent an interactive site for activated factor X. Biochemistry 2002; 41: 12715–12728
   PubMed Web of Science ®Google Scholar